Oncology

A study examining differences between men and women receiving immune or targeted cancer therapies found that women faced more adverse events than men, just as they face more adverse events with chemotherapy, according to the Journal of Clinical Oncology.

Yale researchers discovered that the epigenetic regulator gene cat eye syndrome chromosome region candidate 2, or CECR2, is responsible for driving breast cancer metastasis. 

News about potential negative consequences when prescribing metformin for cancer patients was Becker's most-read oncology story in February. 

Anatoly Nikolaev, MD, PhD, has joined the Cleveland Clinic Weston (Fla.) Maroone Cancer Center. 

The financial relief of medical crowdfunding is often accompanied by feelings of shame in asking for help, a study published in the Journal of Cancer Survivorship suggests.

Raleigh, N.C.-based UNC Rex Healthcare opened a new cancer center March 1. 

About 1 in 7 breast cancer cases are overdiagnosed, a study published March 1 in the Annals of Internal Medicine found.

The FDA approved carvykti, a new customized, cell-based treatment from Johnson & Johnson, for the treatment of multiple myeloma, Johnson & Johnson said Feb. 28.

Vanderbilt-Ingram Cancer Center in Nashville, Tenn., has selected Ben Ho Park, MD, PhD, as its new director. 

Yale Cancer Center named its annual Conclave awardees in honor of their outstanding contributions to cancer care and research.